Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Completed × Tinzaparin × Clear all

Phase

Phase 3 4 Phase NA 2 Phase 2 1

Status

Terminated 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma 1

Interventions

Cyclophosphamide 621 Cisplatin 579 Gemcitabine 549 Bevacizumab 527 Carboplatin 518 Paclitaxel 508 Docetaxel 491 Radiotherapy 478 Fluorouracil 354 Oxaliplatin 335 Rituximab 321 Capecitabine 306 Doxorubicin 305 Filgrastim 279 Etoposide 279 Irinotecan 271 Dexamethasone 264 Leucovorin 245 Cetuximab 225 pembrolizumab 221 Cytarabine 203 Bortezomib 194 Trastuzumab 191 Erlotinib Hydrochloride 186 Vincristine 185 Prednisone 185 Nivolumab 182 Pemetrexed 173 fludarabine phosphate 166 Temozolomide 165

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02260414 2017-05-11

METRO B

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Completed

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡